Sign inJoin waitlistJoin the waitlist

Prithviraj Bose

Professor, Co-Section Head of MPNs · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · · ·

History

Co-Section Head of MPNs · University of Texas M D Anderson Cancer Center
Present
Section of Myeloproliferative Neoplasms · University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Hematology and Medical Oncology
University of Oklahoma Health Sciences Center
2004–2007
Internal Medicine
Henry Ford Hospital
2001–2004
University of Calcutta
1997–2001

Research

Ibrutinib and Venetoclax for First-Line Treatment of CLL
New England Journal of Medicine · 2019 · 426 citations
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
Nature Medicine · 2023 · 334 citations
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
The Lancet Haematology · 2020 · 280 citations

SV
Srdan Verstovsek
80 papers
Naveen Pemmaraju
68 papers
Hagop Kantarjian
59 papers
Naval Daver
54 papers
Lucia Masarova
50 papers
Courtney DiNardo
49 papers
Tapan Kadia
49 papers
GB
Gautam Borthakur
48 papers
Elias Jabbour
46 papers
Guillermo Garcia-Manero
42 papers
Nitin Jain
38 papers
ZE
Zeev Estrov
34 papers

Clinical trials

Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2021–2027
Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2017–2020
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
Principal investigator · Terminated · Phase 1
M.D. Anderson Cancer Center
2017–2019
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2016–2024